EMA urged to release full clinical trial data upon authorizing Covid-19 treatments
Amid a worldwide clamor for Covid-19 medicines and vaccines, the European Medicines Agency is being urged by several international clinical evidence experts – including a key German government agency – to publish all trial data on the same day any product is authorized for use against Covid-19.
In a letter to the European regulator, four country directors from the independent watchdog Cochrane and leaders from Germany’s Institute for Quality and Efficiency in Health Care argued that it is critical to promptly release clinical study reports to support further research and proper medical care. The reports are go-to documents that contain myriad details about the methods and results of a clinical trial.
